在ER+乳腺癌中,NF1缺乏驱动了代谢重编程
Rachel Rae J House1, Elizabeth A Tovar1, Luke N Redlon1
1Department of Cell Biology, Van Andel Research Institute, Grand Rapids, MI, USA.
Molecular metabolism
|January 12, 2024
概括
在雌激素受体阳性乳腺癌中,NF1缺乏驱动了代谢重编程,其特征是能量产生变化和脂质合成增加. 这为针对新陈代谢途径和传统抑制剂的联合治疗创造了新的治疗机会.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢研究研究 代谢研究
背景情况:
- 神经纤维素1 (NF1) 是一种瘤抑制基因,其功能丧失是27%零星乳腺癌的重要驱动因素.
- NF1突变与乳腺癌的死亡率增加和较差的结果有关,特别是在雌激素受体阳性 (ER +) 亚型中.
- 以前的研究已经探索了RAS突变在瘤代谢中的作用,但对NF1缺乏乳腺癌代谢的全面分析尚不够.
研究的目的:
- 阐明NF1缺乏在ER+乳腺癌中的代谢重编程中的作用.
- 为了确定潜在的向疗法和NF1缺乏ER+乳腺癌的组合策略.
主要方法:
- 利用ER+乳腺癌的NF1缺乏的MCF7细胞系 (零星) 和NF1缺乏的老鼠模型 (NF相关).
- 评估了细胞增殖,蛋白质表达 (Western Blot) 和全球/代谢相关的转录 (RNAseq).
- 测量了细胞能量 (海马分析),代谢物纳入 (稳定同位素标记,质谱学) 和药物协同作用 (布利斯模型).
主要成果:
- 缺少NF1增加了扩散,RAS/PI3K/AKT信号,增加了谷氨酸的流入和脂质池 (甘油三).
- 在NF1缺陷模型中观察到受限的氧化ATP生产和减少的能量灵活性.
- NF1缺乏改变了代谢抑制剂 (糖解,谷氨酸,脂肪酸,TG合成) 和向疗法之间的协同作用.
结论:
- 在ER+乳腺癌中,NF1缺陷显著重编程新陈代谢,具有氧化ATP限制,增加了谷氨酸的利用率和扩大了脂质合成.
- 这些代谢变化为在NF1缺乏乳腺癌中将代谢抑制剂与向治疗结合起来提供了新的协同机会.
更多相关视频
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
597
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.8K
相关概念视频
The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Introduction to Nuclear Reprogramming
1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
